CARA Snapshot
Cara Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on itching and pain by selectively targeting kappa opioid receptors in the United States. The company is headquartered in Stamford, Connecticut.
Market Capitalization$657,162,000
Price to Sales16.67
Earnings per Share$-1.8000
PE RatioNone
Most Recent Close$11.2400
52 Week High$13.96
52 Week Low$7.4
50-Day Moving Average$10.29
200-Day Moving Average$10.24
All data are from Alpha Vantage as of today. For more infomation on CARA see Stock Dividend, Valuation, Price and Financial Data for Investors